Abstract
AbstractPaget disease of bone is a metabolic disorder with a strong genetic component, characterised by pronounced disorganised bone remodelling. Complications of this disease include an increased risk of developing bone neoplasms. Here, we describe the case of a 60-year-old Italian patient with Paget disease of bone, presenting with an osteoclast-rich tumour. Our analysis of this entity, based on the clinical, morphological and genetic data (whole exome sequencing), suggests that osteoclast-rich lesions in Paget disease of bone are genetically distinct from classical giant cell tumour of bone. We discuss the importance of differentiating these osteoclast-rich lesions.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference9 articles.
1. Gennari L, Rendina D, Merlotti D, Cavati G, Mingiano C, Cosso R, et al. Update on the pathogenesis and genetics of Paget’s disease of bone. Front Cell Dev Biol. 2022;10:932065.
2. Gong L, Bui MM, Zhang W, Sun X, Zhang M, Yi D. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Histol Histopathol. 2021;36:61–8.
3. Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del Fattore A, et al. ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor. Am J Hum Genet. 2016;98:275–86.
4. Wei Z, Li S, Tao X, Zhu G, Sun Z, Wei Z, et al. Mutations in profilin 1 cause early-onset Paget’s disease of bone with giant cell tumors. J Bone Miner Res Off J Am Soc Bone Miner Res. 2021;36:1088–103.
5. Cottone L, Ligammari L, Lee H-M, Knowles HJ, Henderson S, Bianco S, et al. Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone. Cell Death Differ. 2022;29:2459–71.